Concurrent mutations of RB1 and TP53 genes were also found in the majority of CTCs from a lung cancer patient who experienced a phenotypic transition from adenocarcinoma to small-cell lung cancer (SCLC) [43]. This evidence concerns the gene RB1 and small cell lung carcinoma.